Analysis of Pulmonary Vasodilator Responses to SB-772077-B [4-(7-((3-Amino-1-pyrrolidinyl)carbonyl)-1-ethyl-1H-imidazo(4,5-c)pyridin-2-yl)-1,2,5-oxadiazol-3-amine], a Novel Aminofurazan-Based Rho Kinase Inhibitor
Authors:
- Adeleke M. BadejoABAdeleke M. Badejo
- David B. CaseyDCDavid B. Casey
- Subramanyam N. MurthySMSubramanyam N. Murthy
- Philip J. KadowitzPKPhilip J. Kadowitz
- 1 July 2009
- journal article
- research article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 330 (1) , 334-341
Abstract
The effects of SB-772077-B [4-(7-((3-amino-1-pyrrolidinyl)carbonyl)-1-ethyl-1H-imidazo(4,5-c)pyridin-2-yl)-1,2,5-oxadiazol-3-amine], an aminofurazan-based Rho kinase inhibitor, on the pulmonary vascular bed and on monocrotaline-induced pulmonary hypertension were investigated in the rat. The intravenous injections of SB-772077-B decreased pulmonary and systemic arterial pressures and increased cardiac output. The decreases in pulmonary arterial pressure were enhanced when pulmonary vascular resistance was increased by U46619 [9,11-dideoxy-11α,9α-epoxymethanoprostaglandin F2α], hypoxia, or Nω-nitro-l-arginine methyl ester. SB-772077-B was more potent than Y-27632 [trans-4-[(1R)-1-aminoethyl]-N-4-pyridinyl-cyclohexanecarboxamide dihydrochloride] or fasudil [5-(1,4-diazepane-1-sulfonyl)isoquinoline] in decreasing pulmonary and systemic arterial pressures. The results with SB-772077-B, fasudil, and Y-27632 suggest that Rho kinase is constitutively active and is involved in the regulation of baseline tone and vasoconstrictor responses. Chronic treatment with SB-772077-B attenuated the increase in pulmonary arterial pressure induced by monocrotaline. The intravenous injection of SB-772077-B decreased pulmonary and systemic arterial pressures in rats with monocrotaline-induced pulmonary hypertension. The decreases in pulmonary arterial pressure in response to SB-772077-B in monocrotaline-treated rats were smaller than responses in U46619-infused animals, and the analysis of responses suggests that approximately 60% of the pulmonary hypertensive response is mediated by a Rho kinase-sensitive mechanism. The observation that Rho kinase inhibitors decrease pulmonary arterial pressure when pulmonary vascular resistance is increased by interventions such as hypoxia, U46619, angiotensin II, nitric-oxide synthase inhibition, and Bay K 8644 [S-(-)-1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-[trifluoromethyl]phenyl)-3-pyridine carboxylic acid methyl ester] suggest that the vasodilatation is independent of the mechanisms used to increase intracellular calcium and promote vasoconstriction. The present results suggest that SB-772077-B would be beneficial in the treatment of pulmonary hypertensive disorders.Keywords
This publication has 35 references indexed in Scilit:
- Pulmonary vasodilator responses to sodium nitrite are mediated by an allopurinol-sensitive mechanism in the ratAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Analysis of pulmonary vasodilator responses to the Rho-kinase inhibitor fasudil in the anesthetized ratAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- Oxidant and Redox Signaling in Vascular Oxygen Sensing: Implications for Systemic and Pulmonary HypertensionAntioxidants & Redox Signaling, 2008
- Rho kinase and Ca2+entry mediate increased pulmonary and systemic vascular resistance inl-NAME-treated ratsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2007
- Rho Kinase–Mediated Vasoconstriction Is Important in Severe Occlusive Pulmonary Arterial Hypertension in RatsCirculation Research, 2007
- Acute Vasodilator Effect of Fasudil, a Rho-kinase Inhibitor, in Monocrotaline-Induced Pulmonary Hypertension in RatsJournal of Cardiovascular Pharmacology, 2007
- Rho-kinase as a Potential Therapeutic Target for the Treatment of Pulmonary HypertensionDrug News & Perspectives, 2006
- Rho/Rho kinase signaling mediates increased basal pulmonary vascular tone in chronically hypoxic ratsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2004
- Activation of RhoA and Inhibition of Myosin Phosphatase as Important Components in Hypertension in Vascular Smooth MuscleCirculation Research, 2003
- Inhibition of sustained hypoxic vasoconstriction by Y‐27632 in isolated intrapulmonary arteries and perfused lung of the ratBritish Journal of Pharmacology, 2000